Kymera Therapeutics · 2 days ago
Vice President or Senior Vice President, Clinical Development Operations
Kymera Therapeutics is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop innovative medicines. The Vice President or Senior Vice President of Clinical Development Operations will provide leadership and oversight for global trial execution, ensuring quality and compliance while collaborating across various functions to align strategy with operational delivery.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Provide visionary leadership across Clinical Development Operations, cultivating a high-performing, collaborative culture
Oversee end-to-end global trial execution across multiple programs and phases, with a focus on quality, timeliness, and budget adherence
Build and scale operational capabilities, including process optimization, systems implementation, and inspection readiness
Collaborate cross-functionally with Clinical Development, PM and Program Leader, Regulatory, Data Sciences, Safety, and CMC to align program strategy with operational delivery
Lead vendor strategy and governance for CROs, central labs, and other external partners, ensuring accountability and performance
Actively contribute to strategic planning, scenario modeling, and regulatory submissions for global programs
Ensure trials meet the highest standards of GCP compliance, patient safety, and data integrity
Serve as a key member of Kymera’s development leadership team, and on our R&D program review meetings, helping shape the broader clinical strategy and culture
Qualification
Required
Bachelor's Degree and 15+ years of clinical operations leadership experience, with a strong track record managing global trials across phases (esp. Ph2–Ph3), ideally in immunology/inflammation and/or large scale trials
Demonstrated success building and leading large, multi-disciplinary teams in dynamic, matrixed environments
Expertise in vendor oversight, budget and resource planning, and cross-functional team alignment
Deep understanding of regulatory requirements and global GCP/ICH guidelines
Inspirational people leader with excellent communication, decision-making, and change management skills
Mission-driven, solutions-oriented, and thrives in a fast-paced biotech setting
Benefits
Eligibility for annual bonus
Equity participation
Comprehensive benefits
Company
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Funding
Current Stage
Public CompanyTotal Funding
$1.96BKey Investors
Biotechnology Value FundAtlas Venture
2025-12-10Post Ipo Equity· $602M
2025-06-26Post Ipo Equity· $250.8M
2024-08-19Post Ipo Equity· $225M
Leadership Team
Recent News
2025-12-11
Company data provided by crunchbase